Startup profile · funding coverage
Omada Health
Virtual chronic-care platform for diabetes, hypertension, and musculoskeletal conditions.
Stage
public
Status
public
Coverage
full
Why Omada Health is interesting
Digital health OG that reached public markets — a16z led Series B (2014) and held ~9.6% pre-IPO; Norwest and USVP were long-time co-investors before June 2025 IPO (OMDA).
Key facts
- Series B (2014): led by a16z (Forge, Business Insider)
- IPO (Jun 2025): priced at $19/share on Nasdaq (OMDA); a16z held ~8–10% pre-IPO (TechCrunch, SEC 424B4)
- Co-investors not in VCT directory: U.S. Venture Partners, Revelation Partners, Wellington Management
Investors in our directory
Funds linked from Omada Health's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Enterprise SaaS
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
Market / IPO context
Ticker: OMDA (Nasdaq)
IPO status: public
IPO date: 2025-06-06
Editorial / static context — not a live quote.
FAQs about Omada Health
Funding context and why this company shows up in venture coverage.
Omada Health is listed among Andreessen Horowitz (a16z) investments on a16z’s public investment list.
We track a16z-backed companies that are strategically relevant for founders and investors following AI, American Dynamism, crypto, bio, and enterprise software.
Last updated: 2026-07-24